Vanda Pharma Investor Accuses Brass Of Off-Label Marketing
A Vanda Pharmaceuticals Inc. investor filed a derivative suit in Delaware federal court Wednesday claiming company officers covered up a "widespread" off-label marketing scheme to sell two drugs to patients they...To view the full article, register now.
Already a subscriber? Click here to view full article